Company Update MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Marksans Pharma Limited''s wholly owned subsidiary Relonchem Limited receives market authorization for the product Cyanocobalamin 50mg film coated tablets